Report of the GUDID Clinically Relevant Size (CRS) Work Group

By AHRMM

Related Resources

Advisory
UDI and Adverse Event Reporting Advisory
The Food and Drug Administration (FDA) UDI system is being phased in over several years.
Letter/Comment
AHRMM Comment Letter to FDA Regarding the Draft Guidance for Industry on the Global Unique Device Identification Database (GUDID)
On November 21, 2013, AHRMM submitted electronically
Letter/Comment
Recent Guidance on Meaningful Use of EHRs Makes Compliance More Difficult
Recent Guidance on Meaningful Use of EHRs Makes Compliance More Difficult.
Issue Brief
Alarm Safety Management
This learning lab covers alarm safety management in the health care supply chain field.
Advisory
CMS Releases Proposed Rule for Hospital Value-Based Purchasing Program
The Patient Protection and Affordable Care Act of 2010 (ACA) requires the Secretary of Health and Human Services to establish a VBP program t
On-Demand Educational Webinars
Service Contracts: Impacting the Total Cost of Ownership